2024 International Congress Archives - Page 80 of 181

Can gait instability indicate the cognitive function of people with Parkinson’s disease?

SM. Cheon, JW. Kim, JS. Hwang, CH. Youm (Busan, Republic of Korea)
Can Heterozygous Autosomal Recessive Mutations Cause Neurological Disease?

L. Patil, M. Bhatt (Mumbai, India)
Can Simple Home Based Exercises Reduce the Fear of Falling in Parkinson Disorders?

R. Neupane, P. Kukkle (Bangalore, India)
Can Square Wave Jerks Differentiate Progressive Supranuclear Palsy from Parkinson’s Disease? A Scoping Review

Y. Xu, N. Bellacicco, E. Feinstein (Newark, USA)
Can Technology Improve Service Delivery and Patient Outcomes in a Parkinson’s Speech and Language Therapy Clinic?

C. Meskill, C. Bartliff, J. O'Loughlin (Cork, Ireland)
Can We Rid Uganda of the Societal Myth That Parkinson’s Disease Is Witchcraft?

S. Klingelhofer, H. Tamale, G. Mogan (Tillamook, USA)
Candidate biomarkers of EV-microRNA in detecting REM sleep behavior disorder and Parkinson’s disease

Y. Li, J. Liu, L. Wu (shanghai, China)
CANVAS and Sleep Disorder: a Prospective Cross-Sectional Study

A. Funcis, G. Dalla Zanna, S. Rossi, F. Madia, G. Silvestri, V. Brunetti (Rome, Italy)
CANVAS: think to assess cognition!

K. Dujardin, C. Tard, E. Diglé, V. Herlin, E. Mutez, JB. Davion, A. Wissocq, V. Delforge, G. Kuchcinski, V. Huin (Lille, France)
CAPRIN1 defect: a new severe neurodegenerative disorder with childhood dementia, myoclonus-ataxia, and sensorimotor neuropathy

R. Bove, A. Torella, G. Ricciardi, L. Pollini, M. Novelli, F. Pisani, V. Nigro, V. Leuzzi, S. Galosi (Rome, Italy)
Carbidopa does not cause changes in QTc interval even at a supratherapeutic dose

R. Kleiman, J. Mickelson, R. Sanwo, C. Edwards, S. Fisher, H. Visser (South Gate, USA)
Cardiac Mitochondrial Complex I Integrity Predicts Axial Symptom Severity in Parkinson’s Disease

S. Roytman, G. Carli, R. Vangel, P. Kanel, R. Koeppe, N. Bohnen (Ann Arbor, USA)
Cardiovascular Associations of Cortical Lewy Bodies in the Oldest Old: The 90+ study

R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)
Cardiovascular Risk Profile in Patients with Primary Familial Brain Calcification

B. Snijders, M. Peters, P. de Jong, B. Lith, E. Brilstra, Y. Ruigrok, V. Schepers, E. van Valen, M. Emmelot-Vonk, H. Koek (Utrecht, Netherlands)
Case Report Functional Neurological Disorder as a Harbinger of Spinocerebellar Ataxia 8

S. Jimsheleishvili, D. Crandon, J. Margolesky (Miami, USA)
Case Report Increasing ‘On-time’ Using Mucuna pruriens Concomitantly with Traditional Levodopa/carbidopa Management

T. Denne (United States, USA)
Case Report of Spinocerebellar Ataxia 13 Presenting with Pure Cerebellar Ataxia

S. Park (Daejeon, Republic of Korea)
Case Report: An Unusual Case of Corticobasal Syndrome

A. Ly, M. King, C. Sherer, J. Crook, A. Schindler, L. Danielian, K. Porter, A. Snyder, J. Kwan, S. Scholz (Bethesda, USA)
Case Report: Carbamazepine-Induced Dystonia, Tremor and Negative Myoclonus

D. Ouhabi, H. Naciri Darai, H. Tibar, W. Regragui (Rabat, Morocco)
Case Studies of Real-World Brain Sensing Showing Patient-Specific Trends to Inform Therapy Management in Parkinson’s Disease

A. Nourmohammadi, E. Fehrmann, A. Holt-Becker, R. Raike (New Brighton, USA)
Catalan MSA Registry (CMSAR): Applying new Clinical Criteria and Biomarkers for Increasing Diagnostic Accuracy, is New Better?

A. Pérez-Soriano, C. Painous, J. Pérez, M. Fernandez, Y. Compta, Consortium, MJ. Martí (Barcelona, Spain)
Causal effects of sarcopenia-related traits on risk and progression of Parkinson’s disease: a Mendelian randomization study

T. Wang, J. Geng, R. Han, X. Zeng, J. Peng, YE. Huh (Xi’an, China)
Central Tremor after CAR-T Cell Therapy: A Case with Neurophysiologic Characterization

O. Halhouli, Z. Ni, H. Cho, M. Hallett (Bethesda, USA)
Centralizing brain tissue donation for a large multi-site Parkinson’s disease (PD) study

L. Heathers, T. Foroud, G. Antonopoulos, K. Mantravadi, B. Lenfert (Indianapolis, USA)
Cerebral metabolic network in PLA2G6-associated parkinsonism

XY. Zhou, J. Wang, C. Chen, FT. Liu, CT. Zuo, JJ. Wu, YM. Sun, J. Wang (Shanghai, China)
Cerebral vasoreactivity in patients with Parkinson’s disease and Diabetes Mellitus

A. Martínez-Rodríguez, M. Cansino-Torres, D. Ortiz-Zacarias, S. Castillo-Torres, F. Góngora-Rivera, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)
Cerebrovascular Reactivity and Glymphatic Clearance in Parkinson’s disease

S. Ryman, E. Erhardt, N. Shaff, A. Dodd, N. Hoffman, S. Nitschke, K. Julio, G. Suarez-Cedeno, A. Deligtisch, D. Sugar, H. Lin, A. Vakhtin, HJ. Van-Der-Horn, S. Pirio Richardson, A. Mayer (Albuquerque, USA)
Cervical dystonia after cerebellar stroke and medullary hemorrhage

I. Sarac, H. Sarac, F. Borovecki, N. Henigsberg, Z. Kresic (Zagreb, Croatia)
Cervical Dystonia Objectively Measured with Wearable Sensor System

B. Dahlben, P. Mulcahey, S. Lee, A. Norain, R. Ghazi, N. Bukhari-Parlakturk (Durham, USA)
Cervical percutaneous interferential current stimulation improves cough reflex and oral residue in patients with Parkinson’s disease

M. Nakamori, M. Toko, H. Yamada, Y. Hayashi, K. Yoshikawa, A. Hiraoka, M. Yoshikawa, T. Nagasaki, Y. Mikami, H. Maruyama (Hiroshima, Japan)
Cervical Vestibular-Evoked Myogenic Potentials in Patients with Parkinson’s Disease

E. Abed (Cairo, Egypt)
Challenges in Wilson disease management in a resource-limited country: a case report from a tertiary center

M. Soares, M. Santiago, A. Simeão, H. Galvão, P. Fontana, F. Travassos, M. Ramalho, R. Mendonça (Recife, Brazil)
Challenges of Huntington’s disease and chorea in Guinea: the benefits of genetic testing in tropical environments

G. Carlos Othon, A. Agsha, H. Lee, M. Rizig, A. Cisse (Conakry, Guinea)
Changes In Glucose Metabolism In Essential Tremor: Within And Beyond The Cerebello-Thalamo-Cortical Circuit

S. Jonker, J. Dalenberg, D. Peretti, AMM. vd Stouwe, MAJ. Tijssen (Groningen, Netherlands)
Changes in Gut Microbiome of Parkinson’s disease Patients using Photobiomodulation Therapy

B. Bicknell, G. Herkes, A. Liebert, H. Kiat (, Westmead, Australia)
Changes in Parkinson’s Disease and Parkinsonian Syndromes A Comparative Retrospective Study in Kyrgyzstan

S. Medetbekova, B. Nurbekova (Bishkek, Kyrgyzstan)
Changes in Postural Control of Patients with Normal Pressure Hydrocephalus After Lumbar Puncture

Z. Kosutzka, I. Straka, L. Hapakova, J. Pucik, M. Saling (Bratislava, Slovakia)
Changes in slow-wave sleep characteristics in Parkinson’s disease patients with depression

C. Mao, J. Hu, Y. Wang, X. Cheng, J. Liu, F. Wang, C. Liu (Suzhou, China)
Characterisation and longitudinal significance of subjective cognitive decline in GBA and LRRK2 Parkinson’s disease

L. Batzu, D. Urso, S. Rota, A. Podlewska, MA. Qamar, KR. Chaudhuri (London, United Kingdom)
Characterisation of the Pattern of Daily Motor Fluctuations in Patients with Parkinson’s Disease and Early Motor Fluctuations: Findings from the Korean ADOPTION Study

J. Lee, J. Ferreira, H. Ma, J. Rocha, B. Jeon (Seoul, Republic of Korea)
Characterisation of the pharmacokinetic profile of amantadine in the common marmoset

D. Bédard, F. Gaudette, S. Nuara, F. Beaudry, P. Huot (Montreal, Canada)
Characterising early morning akinesia and off (EMO) using Parkinson’s kinetigraph: analysis from a two centre national database in Parkinson’s disease .

K. Poplawska-Domaszewicz, D. Trivedi, K. Ray Chaudhuri (Poznan, Poland)
Characteristics and Treatment Patterns of Patients Newly Diagnosed With Essential Tremor: A Retrospective Claims Database Analysis in the US

J. Williams, R. Pahwa, L. Barbato, J. Lin, F. Tefos, A. Sillah, S. Thomas, F. Geng, Y. Pan, J. Friderici, S. Shah (Bakersfield, USA)
Characteristics of Language Abnormalities in Multiple System Atrophy and Parkinson’s Disease

M. Subert, M. Novotny, P. Dusek, J. Klempir, J. Rusz, T. Tykalova (Prague, Czech Republic)
Characteristics of Parkinson’s disease and associated healthcare resource utilization trends in a US all-payer health administrative claims database

W. Zhang, S. Shuvo, A. Gabriel, A. Yaldo, G. Agreda, C. Goetzsche, T. Machewitz, M. Nadimi, J. Lott (Whippany, USA)
Characteristics of tremor frequency oscillatory neurons in the basal ganglia and thalamus in Parkinson’s tremor

P. Zhuang, M. Meng, Y. Zhang, J. Li, J. Li, Y. Hu, M. Hallett, Y. Li (Beijing, China)
Characteristics of vegetative disorders in Parkinson’s disease patients with Covid-19

O. Naimov, R. Matmurodov, B. Muminov (Tashkent, Uzbekistan)
Characterization of a Novel alpha-synuclein PET radiotracer, [18F]C05-05, in a PPMI Sub-study

D. Russell, C. Constantinescu, R. Gunn, J. Eberling, A. Lorenzo, M. Rowland, S. Roman, J. Seibyl, K. Marek, MJF. Imaging Consortium, THE. Ppmi Study (New Haven, USA)
Characterization of Autoimmune Parkinsonism. A case series

W. Trillo Alvarez, C. Ibañez Escalante, A. Escalante Mercado, P. Bermejo Rosado, L. Delgado Villanueva, A. Aquino Toledo, R. Huanca Machon (Arequipa, Peru)
Characterization of Infusion Site Reactions With 24-hour Subcutaneous Infusion of ND0612

W. Poewe, A. Ellenbogen, N. Lopes, R. Pahwa (Innsbruck, Austria)
Characterization of Muscle activity before and during Freezing of Gait Episodes

E. Jafari, S. Pardoel, A. Alakhras, J. Kofman, E. Lemaire, J. Nantel (Ottawa, Canada)
Characterizing Dopaminergic Correlates of Depression in Parkinson’s Disease: The PPMI Cohort

C. Song, A. Basu, I. Bedoy, J. Li, J. Ruiz Tejeda, S. Nguyen, R. Rajmohan, N. Phielipp (Irvine, USA)
Characterizing levodopa-induced dyskinesias using multimodal neuroimaging, clinical and behavioral measures

S. Shukla, S. Tinaz, N. Thirugnanasambandam (Mumbai, India)
Childhood onset progressive myoclonus and ataxia in a patient with novel TBC1D2B gene mutation

M. Gultekin, N. Basak (Kayseri, Turkey)
Cholinergic Basal Forebrain Integrity and Cognition in Parkinson’s Disease

N. Slater, T. Melzer, D. Myall, G. Hall-Mcmaster, A. Harris, K-L. Horne, T. Anderson, J. Dalrymple-Alford (Christchurch, New Zealand)
Cholinergic Brain Signature of Presbyvestibulopathy in Parkinson’s Disease: Exploring Central Nervous System Vestibular Mechanisms

P. Kanel, G. Carli, T. Brown, S. David, R. Vangel, C. Pongmala, D. Mccaslin, K. Kerber, N. Bohnen (Ann Arbor, USA)
Cholinergic brain vulnerabilities associate with diabetic comorbidity in Parkinson disease

G. Carli, P. Kanel, T. Brown, S. Roytman, R. Albin, N. Bohnen (Ann Arbor, USA)
Cholinergic denervation is more severe in patients with Parkinson disease compared to Progressive Supranuclear Palsy-Parkinsonism subtype: A [18F]-FEOBV PET study

P. Kanel, G. Carli, J. Barr, T. Brown, S. Roytman, K. Frey, P. Scott, R. Koeppe, R. Albin, N. Bohnen (Ann Arbor, USA)
Chorea Acanthocytosis Misdiagnosed as Functional Movement Disorder

A. Crutchfield, N. Reddy, A. Ahmed, M. Lotia (Orlando, USA)
Chorea after MRgFUS for the treatment of essential tremor: A case report

A. Ferreirós, AN. Martínez, M. Peralta, J. Bejarano, A. Sánchez-Gómez, F. Valldeoriola, JO. Rumià (Barcelona, Spain)
Choreiform Movements Secondary to Sarcoidosis Without Central Nervous System Granulomatosis

O. Carranza-Renteria, T. Hammond (Boca Raton, USA)
Choreoacanthocytosis: The First Genetically Confirmed Cases From Algeria

Y. Mecheri, S. Talbi, A. Rezigue, M. Zouzou, BS. Fekraoui, F. Serradj, A. M'Zahem (Constantine, Algeria)
Choreoballism due to Bisphosphonate-Induced Antiphospholipid Syndrome: A Case Report

P. Leistikow, N. Joseph, D. Shah-Zamora (Winston-Salem, USA)
Chronic Sleep Fragmentation Accelerates the Onset of Prodromal Symptoms and Pathology in Parkinson’s Disease Model Mice

M. Miyazaki, H. Yagihara, H. Fujita, H. Yamakado, K. Wada, E. Minakawa (Kodaira, Japan)
Chronic striatal cholinergic agonist infusion as a model of dystonia

E. Courtin, B. Ribot, M. Deffains, D. Guehl, P. Burbaud (Bordeaux, France)
Classification of Parkinson’s disease using AI based on multi-modal brain MRI connectomics

T. Teo, T. Welton (Singapore, Singapore)
Classification of Tremor and Myoclonus: An Explainable Machine Learning Approach

E. vd Brandhof, I. Tuitert, A M. vd Stouwe, JW. Elting, J. Dalenberg, M. Biehl, M. Tijssen (Groningen, Netherlands)
Cleaved plasma kininogen is associated with unfavorable cognitive outcome in Parkinson’s disease

I. Markaki, T. Ntetsika, W. Paslawski, P. Tsitsi, S. Carvalho, JC. Corvol, P. Svenningsson (Stockholm, Sweden)
Climate Change Indices and The Vulnerability of Parkinson’s Patients in The MENA Region And North Africa: A Narrative Review

MYA. Amine, F. Essam (Giza, Egypt)
Clinic vs Self-Referral for a Home-Based Fracture Prevention Trial of Zoledronate vs Placebo in Patients with Neurodegenerative Parkinsonism

C. Tanner, N. Luthra, S. Goldman, R. Zuzuarregui, E. Brown, C. Meng, J. Perkins, T. Hue, C. Schambach, D. Kreisel, D. Young, I. Bledsoe, L. Racelo, P. Nanda Kumar, P. Ranola, M. Schwarzschild, R. Dorsey, A. Espay, S. Krischer, J. Falcon, C. Comella, M. Siddiqui, F. Gao, M. Ledoux, E. Byrd, I. Litvan, N. Mcfarland, K. Mitchell, D. Standaert, J. Beck, K. Williams, M. Drake, D. Bauer, K. Lyles, S. Cummings (SAN FRANCISCO, USA)
Clinical and Brain Morphological Characteristics of Early LRRK2-associated Parkinson Disease

Q. Tao, S. Rahayel, C. Tremblay, A. Vo, A. Dagher (Montreal, Canada)
Clinical and Epidemiological Aspects of Neuropsychiatric Features in Patients with Huntington Disease in Chile

J. Fuentes, P. Salles, P. Chaná-Cuevas, C. Montalva, M. Sánchez, N. Rojas (Santiago, Chile)
Clinical and epidemiological profile of Parkinson’s disease in India

A. Kishore, R. Borgohain, KP. Divya, R. Rajan, P. Pal, H. Kumar, S. Mehta, N. Kumar, LK. Prashanth, S. Desai, R. Kandadai, R. Yadav, K. Shetty, P. Wadi, A. Aggarwal, P. Agarwal, M. Abbas, G. Wali, T. Ferreira, A. Srivastava, N. Kamble, M. Divya, S. Krishnan, L. Gonzalez-Ricardo, M. Chacko, M. Sharma (Kochi, India)
Clinical And Genetic Analysis Of Patients With Parkinson’s Disease -LRRK2 Variants From A Referral Centre In India

S. Rath, PK. Pal, R. Yadav, VV. Holla, N. Kamble (MUMBAI, India)
Clinical and Genetic Characteristics in a Chinese Cohort of Complex Spastic Paraplegia Type 4

L. Yao, YW. Cao, C. Zhang, XJ. Huang, WT. Tian, L. Cao (shanghai, China)
Clinical and genetic characteristics of PLA2G6-parkinsonism in southwest of China and a review of heterogeneity of phenotype and genotype between Asian and Caucasian patients

YF. Cheng, HF. Shang (Chengdu, China)
Clinical and Genetic Profile of Spinocerebellar Ataxias in a Tunisian Cohort

M S. Majoul, R. Zouari, A. Kalfat, R. Amouri, D. Ben Mohamed, M Z. Saied, F. Nabli, S. Ben Sassi (Tunis, Tunisia)
Clinical and Imaging Changes in Parkinson’s Disease Patients Under Spinal Cord Stimulation: A Double Blinded Analysis

R. Carra, L. Garcia, J. Menezes, T. Capato, E. Barbosa, K. Duarte, M. Teixeira, R. Cury (Sao Paulo, Brazil)
Clinical and Neuroimaging Biomarker Predictors of Autonomic Dysfunction in Parkinson’s Disease: A Study Using PPMI Data

A. Oliveira Franco, M. Machado Schlindwein, J. Rossi Catao, D. Teixeira-Dos-Santos, A. Bieger, T. Hugentobler Schlickmann, L. Angi Souza, C. Mattjie, F. Suzuki, G. Magalhães Pereira, L. Silveira Kupssinskü, L. Vinícius Moura, R. Ravazio, S. Duarte Pinto, M. de Bastiani, R. Barros, E. Zimmer, A. Schumacher Schuh (Porto Alegre, Brazil)
Clinical and Neuroimaging Biomarker Predictors of Cognitive Dysfunction In Parkinson’s Disease: A Study Using PPMI Data

M. Schlindwein, A. Franco, J. Catao, D. Teixeira-Dos-Santos, A. Bieger, T. Hugentobler Schlickmann, L. Angi Souza, C. Mattjie, F. Suzuki, G. Magalhães Pereira, L. Silveira Kupssinskü, L. Vinícius Moura, R. Ravazio, S. Duarte Pinto, M. Bastiani, R. Barros, E. R. Zimmer, A. Schuh (Porto Alegre, Brazil)
Clinical and neuroimaging factors associated with survival in Multiple System Atrophy

G. Martí-Andrés, E. Prieto-Azcárate, CA. Espinoza-Vinces, M. Riverol, J. Arbizu, MR. Luquin-Puido (Pamplona, Spain)
Clinical and neuroimaging factors associated with survival in Progressive Supranuclear Palsy

G. Martí-Andrés, E. Prieto-Azcarate, CA. Espinoza-Vinces, L. van Bommel, S. Meles, M. Riverol, KL. Leenders, J. Arbizu, MR. Luquin-Puido (Pamplona, Spain)
Clinical and neurological features of the course of Parkinsonism disease in patients with CKD with cystatin C disorder

S. Khudayarova, G. Rakhmatullayeva (Tashkent, Uzbekistan)
Clinical and Neurophysiological Response of Different Protocols of Non-Invasive Spinal Neuromodulation in Anti-Gad Positive Stiff Person Syndrome: A Case Report

V. Maciel, G. Silva, R. Carra, J. Baima, J. Oliveira, M. Silva, P. Lacerda, K. Massruha, C. Heise, C. Tanaka, R. Cury (São Paulo, Brazil)
Clinical and Radiologic Predictors for a Longer Benefit of Cerebrospinal Fluid Decompression in Normal Pressure Hydrocephalus

J. Lee, M. Sunwoo (Seongnam-si, Republic of Korea)
Clinical and Safety Outcomes Using DBS Systems with Directionality and Multiple Independent Current Control – Real-World, USA Experience

M. Okun, K. Foote, T. Zesiewicz, Y. Bezchlibnyk, A. Papanastassiou, O. Vaou, J. Carlson, J. Aldred, V. Krishna, C. Luca, J. Jagid, J. Durphy, L. Verhagen Metman, S. Sani, S. Ojemann, D. Kern, D. Weintraub, R. Ramdhani, A. Siadati, B. Sundaram, C. Zhao, D. Martinez, M. Siddiqui, S. Tatter, L. Chen, E. Goldberg (Gainesville, USA)
Clinical applications of cortical finely tuned gamma oscillations induced via subthalamic deep brain stimulation in Parkinson’s disease

M. Shcherbakova, S. Cernera, A. Hahn, S. Little, P. Starr (San Francisco, USA)
Clinical Assessment Of Dysautonomia And REM Sleep Behavior Disorders in Essential Tremor

S. Sellami, N. Farhat, N. Bouattour, KS. Moalla, S. Daoued, S. Sakka, M. Damak, C. Mhiri (Sfax, Tunisia)
Clinical benefit of Opicapone in patients with different Parkinson disease phenopytes. The OPTIMO study

MR. Luquin, C. Martin, I. Tegel, I. Pijuan, C. Moreno (Pamplona, Spain)
Clinical characteristics and Brain atrophy pattern in the prospective multicenter cohort of Progressive Supranuclear Palsy

S. Lee, R. Kim, B. Jin, H. Kim, EJ. Yoon, YK. Kim, JH. Shin, HJ. Kim, JY. Lee (Seoul, Republic of Korea)
Clinical Characteristics and Management Practices of Pediatric Status Dystonicus

K. Chesky, J. Gill, S. Thomas, M. Hull (Houston, USA)
Clinical characteristics associated with early discontinuation of Levodopa-Carbidopa Intestinal Gel infusion in patients with advanced Parkinson Disease.

D. Rivero-Rodríguez, M. Morales-Casado, G. Tabar-Comellas, A. Diezma-Martín, P. Quintana-Castro, M. Ennazeh, N. López-Ariztegui (Toledo, Spain)
Clinical characteristics of movement disorders associated with multiple sclerosis patients: A cross sectional preliminary single center results.

MM. Meshref, AF. El-Adawy, FM. Mansour, MH. Moawad, MEL. Elmasry, HG. Gad (Cairo, Egypt)
Clinical correlates of apathy in Parkinson´s disease

J. Arena, L. Fiorentini, C. Obarrio, M. Merello (Buenos Aires, Argentina)
Clinical Correlation of Double Oscillatory Peaks in Parkinson’s Disease with Deep Brain Stimulation

W. Saengphatrachai, S. Akkus, J. Jimenez-Shahed (New York, USA)
Clinical differentiation between dystonic tremor and Parkinson’s disease based on tremor characteristics

T. Tsuboi, K. Sawada, S. Hoshino, M. Higuchi, M. Muto, Y. Ito, M. Hashida, T. Ishizaki, S. Kato, D. Nakatsubo, T. Tsugawa, S. Maesawa, M. Sato, K. Hiraga, T. Uematsu, D. Tamakoshi, D. Fukushima, M. Suzuki, R. Saito, M. Katsuno (Nagoya, Japan)
Clinical effectiveness and safety of staged-bilateral MRgFUS for treating essential tremor, a literature review

E. Natera Villalba, S. Paschen, M. Del Alamo, R. Martinez Fernandez, AK. Helmers (Madrid, Spain)
Clinical features and brain [18F] FDG PET patterns in patients with progressive supranuclear palsy with and without ventricular dilatation

C. Espinoza-Vinces, I. Avilés-Olmos, G. Martí-Andrés, R. Villino-Rodríguez, C. Pérez-Prol, M. Gimeno-Rodríguez, J. Arbizu, MR. Luquin (PAMPLONA, Spain)
Clinical Features of dj1 Gene Mutation Causing Parkinson’s Disease from Single Institution

H. Alhodaif, Y. Alkhodair, A. Aldakheel, S. Alqahtani, S. Boholegah (Riyadh, Saudi Arabia)
Clinical Outcomes and Local Field Potential Characteristics in Bilateral GPi DBS in 2 cases of X-Linked Dystonia Parkinsonism

E. Donlon, C. O'Keefe, G. Mullane, F. Ruggieri, M. Alexander, C. Moran, T. Lynch, C. Fearon, E. Pereira, R. Walsh (Dublin, Ireland)
Clinical Predictors of Impulse Control Disorders in Parkinson’s Disease

T. Breddy, P. Macdonald, K. van Hedger, H. Ganjavi (London, Canada)
Clinical profile of early-onset Parkinson’s disease

S. Peña Martinez, R. Ayala Minero, R. Amaya, A. Medina Escobar, P. Salles (San Salvador, El Salvador)
Clinical Profile of Motor Complications in Parkinson’s Disease Patients at A National Tertiary Hospital In Indonesia

Y. Rapri, A. Jody, A. Tiksnadi, D. Tunjungsari (Depok, Indonesia)
Clinical Response and Reduction in Medication Use After Deep Brain Stimulation Surgery in a Cohort of Parkinson’s Disease Patients in Colombia

T. Lopez Gonzalez, S. Poveda, M. Fonseca, P. Arango, O. Rojas, G. Monsalve, JC. Diez, J. Lobato, O. Bernal Pacheco (Bogotá, Colombia)
Clinical spectrum of repetitive behaviours and neuroimaging findings in adult patients with neurological Disorders: a cross-sectional Observational study

S. Pandey, P. Kumar (Faridabad, India)
Clinical Trends and Clinician Perceptions Regarding Asleep and Awake DBS

Y. Gordeyeva, B. Dalm, L. Almeida, S. de Jesus, A. Fasano, K. Foote, J. Jimenez-Shahed, D. Pathadan, N. Pouratian, J. Rolston, J. Rosenow, D. Safarpour, J. Schwalb, M. Siddiqui, M. Spindler, A. Tsai, J. Wong, L. Metman (Poznan, Poland)
Clinical Trends in Asleep and Awake DBS in North America vs Europe

D. Pathadan, B. Dalm, L. Almeida, S. de Jesus, A. Fasano, K. Foote, Y. Gordeyeva, J. Jimenez-Shahed, N. Pouratian, J. Rolston, J. Rosenow, D. Safarpour, J. Schwalb, M. Siddiqui, M. Spindler, A. Tsai, J. Wong, L. Metmen (Bengaluru, India)
Clinical Utility of Synuclein Skin Biopsy in the Initial Diagnosis and Evaluation of Parkinsonian Disorders

J. Isaacson, R. Freeman, C. Gibbons, A. Alshehri (Boston, USA)
Clinical, Neurophysiological, and Biological Insights into Levodopa-Induced Dyskinesias

B. Angeloni, A T. Cimmino, R. Di Iorio, P. Calabresi, G. Di Lazzaro (Rome, Italy)
Clinical, Radiological and Genetic profile of Eight Patients with Genetically Proven Ceroid Lipofuscinosis Neuronal and Movement Disorders

VV. Holla, N. Kamble, G. Arunachal, B. Muthusamy, R. Yadav, PK. Pal (Bengaluru, India)
Clinically implemented sensing-based initial programming of deep brain stimulation for Parkinson’s disease: a retrospective study

A. Fuentes, B. Swinnen, M. Volz, S. Heath, P. Starr, S. Little, J. Ostrem (Palo Alto, USA)
Clinico- radiological profile of four patients with CSF1R- related leukoencephalopathy: A case series from India

R S. Harishma, N. Kamble, P. Pal, V V. Holla, R. Yadav, S. Prasad (Bengaluru, India)
Clinico-genetic profile of five patients with PARK-PINK1: A case series from India

A. Gunasekaran, P K. Pal, R. Yadav, N. Kamble, V. Holla (Bangalore, India)
Clinico-radiological and genetic profile of patients with Ataxia with Oculomotor apraxia type-2 (AOA2)- A case series from India

M. Chandarana, B. Tilva, A. Agarwal, D. Garg (Ahmedabad, India)
Clinico-radiological Spectrum and Predictors of Disease Severity in Neurological Wilson Disease: A Single Center Observational Study.

A. Ranjan, R. Solanki, N. Sinha (Patna, India)
Clonazepam as First-Line Therapy for Post-Hypoxic Chorea: A Case Report and Discussion

G. Chu, R. Koshy, A. Maleki (moreno valley, USA)
Closed-Loop Spinal Cord Stimulation: A Case Report on a Novel Therapeutic Approach for Post-Hypoxic Myoclonus

A. Patel, L. Venkatesan (Trevose, USA)
Cluster Analysis of Stimulation-Induced Dysarthria Subtypes in People with Parkinson’s Disease and Subthalamic Deep Brain Stimulation

H. Jergas, JN. Petry-Schmelzer, JH. Hannemann, T. Thies, I. Rubi-Fessen, J. Quinting, V. Visser-Vandewalle, T. Tsuboi, MT. Barbe (Cologne, Germany)
Co-morbid Hypertension and Diabetes and the Relationship to Parkinson’s Disease Motor Phenotype in the Nigeria Parkinson’s Disease Research Network Registry

E. Iwuozo, O. Ojo, O. Agabi, N. Okubadejo, NPD. Research Network (Makurdi, Nigeria)
Coat test: a bedside timed test for quantifying motor function in Parkinson’s disease patients.

C. Holgado, M. Wilken, G. Lopez, M. Merello (Buenos Aires, Argentina)
Codesigning Tech with Patients – Insights from the Quantitative and Qualitative Analysis of Three Technologies used in Patients With Parkinson’s Disease

D. Pérez-Rangel, M. H.G. Monje, S. Grosjean, M. Srp, L. Antunes, R. Bouça-Machado, R. Cacho, S. Domínguez, J. Inocentes, T. Lynch, A. Tsakanika, D. Fotiadis, G. Rigas, E. Ruzicka, J. Ferreira, A. Antonini, N. Malpica, T. Mestre, A. Sánchez-Ferro (Madrid, Spain)
Cognitive function of patients with Parkinson´s Disease after Deep Brain Stimulation: a gene- and variant-based approach

E. Asimakidou, G. Xiromerisiou, C. Sidiropoulos (Cambridge, United Kingdom)
Cognitive Impairment in a Cohort of Patients with DBS for parkinson’s disease treatment from a multicentric Cohort in Colombia

T. Lopez Gonzalez, S. Poveda, M. Fonseca, P. Arango, O. Rojas, G. Monsalve, J. Diez, J. Lobato, O. Bernal Pacheco (Bogota, Colombia)
Cognitive load in a diagnostic electrophysiologic assessment of functional tremor.

K. Evdokimov, E. Fedotova, A. Broutian, S. Illarioshkin (Moscow, Russian Federation)
Cognitive Outcome in Pantothenate Kinase-Associated Neurodegeneration (PKAN) Treated with Deep Brain Stimulation (DBS):Case Report

C. Palmese, M. Pozo, B. Kopell (New York, USA)
Cognitive Performance in Early Neuronal alpha-Synuclein Disease

D. Weintraub, M. Brumm, A. Nair, M. York, R. Dobkin, K. Marek, C. Tanner, T. Simuni, A. Siderowf, D. Galasko, L. Chahine, C. Coffey, K. Merchant, K. Poston, T. Foroud, B. Mollenhauer, E. Brown, K. Kieburtz, M. Frasier, T. Sherer, S. Chowdhury, R. Alcalay, A. Videnovic (Ardmore, USA)
Cognitive profile of Parkinson’s disease (PD) in the Framingham Heart Study (FHS)

A. Gurnani, J. Dookhy, Y. Liu, Y. Li, S. O'Shea, S. Frank, R. Au, J. Mez, T. Alvin Ang, L. Shih (Framingham, USA)
Cognitive Reserve and Motor Subtypes of Parkinson’s Disease

A. Deleón Pérez, S. Castillo Torres, J. Trejo Ayala, I. Estrada Bellmann, B. Chávez Luévanos, P. Téllez Hernández, D. Ortiz Zacarias (Monterrey, Mexico)
Cognitive Reserve may influence Executive Function in Parkinson’s Disease.

J. Trejo-Ayala, P. Téllez-Hernández, S. Castillo-Torres, D. Ortiz-Zacarias, A. de León-Pérez, B. Chávez-Luevanos, I. Estrada-Bellmann (Monterrey, Mexico)
Cognitive Side Effects to Initial Levodopa Exposure as a “Red Flag”: A Retrospective Study

A. Huang, A. Wise, V. Shanker (New York, USA)
Cognitive status in patients with akinetic-rigid and tremor-dominant forms of Parkinson’s disease in Tajikistan.

M. Mirqosimova (Dushanbe, Tajikistan)
Cognitive, Non-Motor, and Quality of Life Outcomes After STN or GPi DBS for Parkinson’s Disease: An Interim Report from the ADROIT NAPA Sub-Study

M. Potter-Nerger, A. Gharabaghi, C. Torres Diaz, A. Schnitzler, S. Chen, L. Himes, M. Frassica, D. Nanduri, S. Groppa (Hamburg, Germany)
Cohort effects on risk scores and risk markers for Parkinson’s disease – comparison of an online-recruited versus population-based cohort

K. Marini, C. Theyer, C. Horlings, H. Stockner, K. Schwarzová, I. Egner, A. Djamshidian-Tehrani, G. Rungger, P. Willeit, J. Willeit, S. Kiechl, M. Martì, A. Garrido, E. Tolosa, B. Mollenhauer, C. Trenkwalder, S. Schade, R. Krüger, V. Satagopam, K. Rege, S. Ghosh, T. Marques, D. Mcintyre, K. Seppi, W. Poewe, P. Mahlknecht (Innsbruck, Austria)
Cohort study and Review on Physiotherapy in the Rehabilitation and Pro-longed Bed Rest of Atypical Parkinsonism’s Syndrome Patients

A. Mimpriss, J. Donnelly, L. Massey, B. Ghosh (Plymouth, United Kingdom)
Combined application of alpha-synuclein and 4-repeat tau seed amplification assays for the differential diagnosis of parkinsonian disorders

E. Jabbari, E. Artikis, C. Orru`, D. Vaughan, N. Vijiaratnam, R. Fumi, M. Theilmann Jensen, M. Hodgson, T. Georgiades, L. Wu, D. Lux, R. Obrocki, B. Groveman, A. Hughson, O. Ansorge, K. Allinson, T. Warner, Z. Jaunmuktane, A. Misbahuddin, N. Leigh, B. Ghosh, K. Bhatia, A. Church, C. Kobylecki, M. Hu, J. Rowe, C. Blauwendraat, T. Foltynie, H. Morris, B. Caughey (London, United Kingdom)
Combining alpha-synuclein PET and seeded amplification assays to improve the diagnostic accuracy of Multiple System Atrophy of the Parkinsonian subtype (MSA-P)

D. Rodriguez Gomez, B. Changizi, C. Sandiego, A. Green, A. Kuzkina, J. Alexander, O. Laun, K. Jones, D. Ceku, J. Meehan, S. Perumalla, S. Rai, A. Knorr, V. Hliva, M. Kosco-Vilbois, A. Pfeifer, N. Mendonca, D. Russell, F. Capotosti, V. Khurana (Boston, USA)
Combining Carbidopa/levodopa Extended-release Capsules and Immediate-release Tablets – Crucial Factors of This Economical Prescription

Y. Tai, S. Hsu, H. Kuo (Kaohsiung City, Taiwan)
Combining EMG and Simulation-Based Biomarkers to Enhance Parkinson’s Resting Tremor Diagnosis

JRV. Rey Vilches, ST. Tolu (Kongens Lyngby, Denmark)
Combining MDS-UPDRS Parts 1 and 2: using the patient’s voice

C. Goetz, H. Zou, G. Stebbins, A. Schrag, T. Mestre, S. Luo (Chicago, USA)
Common and specific immediate effects in brain oscillations and motor symptoms of tDCS and tACS in Parkinson’s disease: A randomized controlled trial

JJ. Bu, JF. Liu, H. Wan, C. Jin (Hefei, China)
Common Genetic Variation Associated with Parkinson’s Disease Biological Measures

EN. Somerville, K. Senkevich, M. Ta, E. Yu, H. Iwaki, Z. Gan-Or (Montreal, Canada)
Common Genotypes Of Dystonia and Response To DBS; Tertiary Center Experience

A. Aldakheel, H. Alhodaif, Y. Alkhodair, H. Alfaris (Riaydh, Saudi Arabia)
Comorbid Tardive Dyskinesia (TD) and Restless Leg Syndrome (RLS)

V. Chang, T. Stiep (San Francisco, USA)
Comorbidities in genetic Parkinson’s Disease: comparison between LRRK2, GBA1, and non-mutated PD

G. Di Rauso, F. Pirone, G. Franco, F. Arienti, I. Trezzi, E. Frattini, F. Cavallieri, V. Rispoli, F. Valzania, E. Monfrini, A. Di Fonzo (Reggio Emilia, Italy)
Comorbidity of schizophrenia and Parkinson’s disease: a clinical case report

M. Khommyatov, M. Samushiya, I. Smolentseva, S. Kryzhanovskiy (Moscow, Russian Federation)
Comparasion of Motor, Non-motor, Social Aspects between Women with Parkinson’s Disease with and Without Sexual Dysfunction

K. Nobrega, B. Alexandre, M. Braga, A. Helene, A. Roque, I. Nascimento, M. Piemonte (Sao Paulo, Brazil)
Comparative Analysis of GAITRite and Moticon Digital Insoles for Gait Assessment in Parkinson’s Disease Patients Before and After Levodopa Administration

R. Acosta, B. Kuyani, S. Stuart, A. Avbersek, P. Rai, S. Mishra, K. Kwei, D. Hall, N. Desai, S. Hamon, J. Urbanek, R. Alaj, O. Harari, M. Wipperman, O. Levy (Tarrytown, USA)
Comparative analysis of opicapone and entacapone in the management of motor fluctuations in patients with Parkinson’s disease, from clinical trials to healthcare resource usage

D. Kremens, F. Amjad, S. Thakkar, B. Naderi, D. Martins, J. Rocha, G. Banisadr, S. Fisher (Wynnewood, USA)
Comparative assessment of cognitive functions of patients with ET and ET plus.

M. Ermakova, Z. Zalyalova, S. Munasipova (Kazan, Russian Federation)
Comparative Effectiveness of Behavioral or Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease

C. Vaughan, J. Morley, J. Lehosit, G. Mcgwin, L. Muirhead, A. Khakharia, T. Johnson Ii, M. Evatt, T. Sergent, K. Burgio, A. Markland (Atlanta, USA)
Comparative Study of Whole-Brain Functional Connectivity Patterns in Parkinson’s Disease and Essential Tremor: A Resting-State fMRI Study

O. Shoraka, S. Naghizadeh Kashani, M. Syed, K. Shivok, T. Liang, R. Sergott, I. Fayed, C. Matias, C. Wu, A. Sharan, M. Alizadeh (Philadelphia, USA)
Comparative-effectiveness of Foscarbidopa/foslevodopa (LDp/CDp) versus Oral Therapies in Advanced Parkinson’s Disease: A Propensity Matched Study

D. Standaert, A. Fasano, F. Ory-Magne, D. Kern, O. de Fabregues, T. Oeda, D. Safarpour, Z. Baldwin, C. Yan, S. Wang, K. Onuk, P. Kukreja, L. Bergmann, V. Fung (Birmingham, USA)
Comparing 18F-AV133 VMAT2 PET and DATscan as Markers of Parkinson’s Disease Severity and Progression

M. Miyasaka, A. Avbersek, M. Ahmed, M. Effendi, O. Harari, L. Pham, S. Somersan-Karakaya, L. Sun, O. Levy, F. Sepehrband (Tarrytown, USA)
Comparing digital gait and turning measures from a prescribed gait test in the clinic/laboratory versus the same test at home in people with Parkinson’s disease

V. Shah, C. Silva-Batista, P. Burgos, A. Ragothaman, P. Carlson-Kuhta, K. Sowalsky, F. Horak, M. Mancini (Portland, USA)
Comparing Pramipexole and Ropinirole in the management of the tremor in Parkinson’s disease in the low-income country and environment of restricted medications.

B. Mukhammedaminov (Uzbekistan, Uzbekistan)
Comparing Ring and Directional Globus Pallidus Stimulation Effects on Parkinson’s Gait

A. Ragothaman, Z. Nhem, G. Harker, P. Carlson-Kuhta, L. Neilson, C. Zarns, M. Case, A. Becker, R. Raike, K. Burchiel, M. Mancini, D. Safarpour (Portland, USA)
Comparing the Selected Device-Aided Therapy of Movement Disorder Specialist Team with Patient Selections

A. de Leon, O. Phokeawvarangkul, R. Bhidayasiri (Bangkok, Thailand)
Comparison Between the 2MWT and the 6MWT as Measures of Walking Capacity in Parkinson’s Disease

H. Johansson, L. Rennie, W. Grooten, B. Leavy (Huddinge, Sweden)
Comparison in Therapeutic Outcome of Ultrasound-Guided Botulinum Injections for Limb Spasticity Versus Dystonia

G. Yahalom, M. Cohen, I. Israel, R. Eichel, Y. Schechter (Jerusalem, Israel)
Comparison of Age, Cognitive, Autonomic, and Motor Testing between Serotonergic vs Idiopathic REM-Sleep Behavior Disorder

M. Berns, N. Reddy, H. Olson, R. Berns, M. Howell (Minneapolis, USA)
Comparison of Composite Method Calculations for Monitoring Disease Progression in Early Parkinson’s Disease

M. Czech, L. Yang, J. Shen, M. Crouthamel, T. Kangarloo, J. Adams, R. Dorsey, J. Cosman (North Chicago, USA)
Comparison of Gastrointestinal Dysfunction in Early-onset and Late-onset Parkinson’s Disease

C. Arora, N. Kamble, V. Holla, R. Mahale, R. Yadav, P. Pal (BENGALURU, India)
Comparison of Monopolar and Bipolar Sensing of Beta Frequency in Parkinson’s Disease of the Subthalamic Nucleus for Deep Brain Stimulation

D. Kern, E. Radcliffe, S. Ojemann, D. Kramer, M. Case, C. Zarns, A. Holt-Becker, R. Raike, A. Baumgartner, J. Thompson (AURORA, USA)
Comparison of Motor, Non-motor, Social Aspects between Men with Parkinson’s Disease with and without Erectile Dysfunction

K. Nobrega, B. Souza, B. Alexandre, M. Silva, A. Frazao, A. Roque, I. Nascimento, ME. Piemonte (Sao Paulo, Brazil)
Comparison of olfactory testing and PSG for detection of alpha-synuclein pathology in patients with dream enactment behavior or REM sleep behavior disorder

E. Brown, L. Chahine, A. Siderowf, C. Gochanour, C. Caspell-Garcia, M. Brumm, M. Marshall, C. Stanley, C. Soto, L. Concha, T. Sherer, T. Tanner, T. Simuni, K. Marek (San Francisco, USA)
Comparison of Spontaneous Brain Activity in Distinguishing Parkinsonian Variant of Multiple System Atrophy from Parkinson’s Disease at Early Stage

S. Wang, Y. Xiao, Y. Hou, C. Li, L. Zhang, R. Ou, Q. Wei, J. Lin, T. Yang, N. Che, Q. Jiang, X. Zheng, J. Liu, H. Shang (Chengdu, China)
Comparison of two methods of deep brain stimulation lead reconstruction and their prediction capacities

R. Barbosa, J. Yamamoto, M. Soares, I. Paraguay, S. Casagrande, J. Dornelly, M. Bezerra, G. Torezani, V. Milanese, G. Micheli, E. Barbosa, R. Cury (Sao Paulo, Brazil)
Complete Resolution of Tardive Dystonia After Bilateral Globus Pallidus Interna Deep Brain Stimulation

L. Okar, P. Murin, C. Pratap (St.Louis, USA)
Complex Movement Disorders in Late Onset TPP1 Gene Mutation (Atypical Neuronal Ceroid Lipofuscinosis Type 2)

M. Soares, T. Coradine, P. Fraiman, V. Procaci, T. Silva, O. Barsottini, J. Pedroso (São Paulo, Brazil)
Complexity of fractal patterns in motor cortical oscillatory activity in rodent models of Parkinson disease

A. Abdulbaki, M. Alam, D. Milakara, J. Krauss, K. Schwabe (Hannover, Germany)
Comprehensive Strategy for Increasing Clinical Research Participation of Black and Hispanic Patients with Parkinsonism

D. Quintana Mora, Y. Mendez, A. Cervera, J. Crary, R. Walker, M. Nirenberg (New York, USA)
Conceptualization of the MDS Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS) prototype.

M. Tosin, T. Mestre, G. Stebbins, G. Mangone, S. Videmsky, S. Ali, D. Aarsland, J. Goldman, T. Khoo, S. Lewis, P. Martinez-Martin, O. Ojo, J. Pagonabarraga, A. Schrag, D. Weintraub, C. Goetz (Chicago, USA)
Concordance of Neuropathologic Diagnosis of Lewy Body Disease with Baseline Alpha-Synuclein Seed Amplification Assay in PPMI

K. Poston, J. Ha, T. Montine, S. Bukhari, T. Foroud, L. Heathers, K. Nudelman, I. Aldecoa, A. Garrido, J. Franz, C. Stadelmann, J-P. Vonsattel, A. Siderowf, L. Chahine, T. Simuni, K. Marek (Stanford, USA)
Connectivity Profile for Increased Apathy Following Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease

E. Abdou, K. Pazira, S. Sharp, J. Summers, K. Dhima, M. Hacker (Nashville, USA)
Connectivity-Based Analysis of the Impact of GPi Deep Brain Stimulation on the Freezing of Gait in Parkinson’s Disease

S. Jo, J. Lee, M. Choi, H. Lee, SJ. Chung (Seoul, Republic of Korea)
Consistent downregulation of rarely reported antioxidant genes viz., GGL, TR, TrX, HO-1, GR, GS, in the mid brain regions among mice and Drosophila exposed to Parkinsonian toxins: Scope as early diagnostic markers

G. Chandran, R. D'Silva, A. Ashok (Mysuru, India)
Constipation in Early-Onset Parkinson’s Disease: frequency, time of onset and association with mortality

C. Piat, A. Mullan, K. Ghoniem, P. Turcano, J. Bower, E. Benarroch, R. Savica (Rochester, USA)
Continuous Dopaminergic Stimulation-based Levodopa Treatment in Early to Mid-stage Parkinson’s Disease Patients: A Systematic Review and Meta-analysis

R. Tang, R. Sun, S. Zhang, L. Chen (Shanghai, China)
Continuous Monitoring of Hypomimia in Parkinson’s disease using a Sensor-equipped Cap

A. Wiederhold, C. Gundler, EM. Lange, F. ückert (Hamburg, Germany)
Continuous Subcutaneous Apomorphine Infusion (CSAI) Improved Confidence When Engaging in Everyday Activities: Survey of InfusON Study Participants

P. Agarwal, A. Formella, N. Crouse, A. Breiteneicher, M. Grall (Kirkland, USA)
Continuous Subcutaneous Apomorphine Infusion for Parkinson Disease Motor Fluctuations: Long-Term Data from the Ongoing InfusON Extension Study

P. Lewitt, S. Isaacson, A. Espay, S. Reyes, A. Formella, G. Ceresoli-Borroni (Detroit, USA)
Contrasting Olfactory Perception in Parkinson’s Disease: Impact of GBA1 Gene Mutations

Y. Schechter, M. Dominko, M. Cohen, G. Yahalom, A. Zimran, S. Revel-Vilk, E. Shulman, T. Dinur, M. Becker Cohen (jerusalem, Israel)
Contribution of Genetics to Onset of PD with Leg Tremor

N. Becker, S. Shah, D. Raymond, M. Rawal, V. Katsnelson, K. Leaver, S. Bressman, R. Saunders-Pullman, C. Young, M. Yang (New York, USA)
Contribution to Efficacy by Active Metabolites of Suvecaltamide in a Preclinical Rat Model of Essential Tremor

N. Shanks, S. Markova, R. Mukkavilli, L. Tan, M. Lee, E. Brigham (Palo Alto, USA)
Coordinated Reset Vibrotactile Therapy for the Treatment of Bradykinesia in Parkinson’s Disease Patients

P. Luu, E. Kabasenche, M. Gutierrez, M. Fisher, B. Gaston, R. Shusterman, K. Morgan, D. Tucker (Eugene, USA)
Correlating Dysarthria with MRI Findings in Temporal Lobe Glioma: Impact of Steroid Therapy on Cerebral Edema

D. Valle, L. Valad, S. Jiang, B. Carr (Gainesville, USA)
Correlation Between Low Hemoglobin Levels and Gait Dysfunction in Huntington’s Disease: An Exploratory Study

H. Kaur, A. Margolius (Cleveland, USA)
Correlation Between Mild Cognitive Impairment and Levodopa Induced Dyskinesia in Parkinson’s Disease Patients

A. Mansour, A. Radwan, S. Ibrahim, N. Elkhayat (Cairo, Egypt)
Correlation Between Sleep and Quality of Life in People With Parkinson’s Disease Treated With Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa

I. Malaty, O. Vaou, R. Hauser, B. Bergmans, P. Odin, M. Shah, L. Bergmann, L. Harmer, R. Gupta, K. Chaudhuri (Gainesville, USA)
Correlation between specific lower limb muscle strength and postural instability and gait difficulties in Parkinson’s disease

M. van Emde-Boas, C. Pongmala, N. Bohnen (Ann Arbor, USA)
Correlation of Clinical Rating Scale for Tremor with Global Assessment

S. Howard, S. Singh, D. Macaluso, J. Hsu, I. Cajigas, L. Qiu, C. Halpern, W. Aamodt, J. Farrar (Philadelphia, USA)
Correlation of lmaging Markers with Clinical Features in Multiple System Atrophy Patients

N. Jin (Hangzhou, China)
Correlation of Neural Sensing with the Volume of Neural Activation within the Desired Patient-Specific Anatomical Target in Deep Brain Stimulation for Parkinson’s Disease

M. Case, C. Zarns, A. Holt-Becker, R. Raike, E. Radcliffe, J. Thompson, D. Kern (Minneapolis, USA)
Cortical activity during visually perturbed gait in older adults

P. Mcdonnell, A. Grimmitt, J. Jaramillo, K. Smith, W. Hoogkamer, D. Martini (Amherst, USA)
Cortical and Subcortical Brain Volume Changes in Idiopathic REM Sleep Disorder Subjects at Risk for Parkinson’s Disease

M. Lima Gregorio, B. Renner, Z. Fan, E. Hogg, C. Malatt, E. Tan, M. Kelly, R. Artal, P. Sati, M. Tagliati (Los Angeles, USA)
Cortical morphometry and subcortical volumetry in motor subtypes of Parkinson’s disease

P. Pal, S. Prasad, T. Nagaraj, S. Bhat, S. Purushotham, R. Taneja, V. Holla, R. Mahale, N. Kamble, R. Yadav, J. Saini (Bengaluru, India)
Cortical myoclonus in DHDDS: the multifaced presentation of a single movement disorder

L. Pollini, M. Novelli, C. Greco, F. Pisani, V. Leuzzi, S. Galosi (Rome, Italy)
Cortical Pencil Lining in Brain MRI of a Patient with Chorea and Hepatic Cirrhosis

S. Casanova, P. Martins, I. Barbosa, M. Malaquias (Vila Nova Gaia, Portugal)
Cortical response to proprioceptive stimulation in orthostatic tremor – a magnetoencephalography study

K. Af Edholm, M. Vinding, C. Pfeiffer, D. Lundqvist, J. Waldthaler (Danderyd, Sweden)
Could Augmented Reality With Biofeedback Be Beneficial In Improvement Of Motor And Non-motor Symptoms In Patients With Parkinson’s Disease?

P. Lisewski, B. Lisewska, M. Wasilewska, W. Fronskiewicz (Bydgoszcz, Poland)
Craniofacial Myoclonus: A Disabling Complication of Amantadine Therapy

S. Bhushan, Mph, S. Brillman, Md (Palo Alto, USA)
Creating a Multi-institutional, Interdisciplinary Functional Neurological Disorder (FND) Clinic in an Urban Setting

D. Kipnis, Z. Grin, S. Leung, Z. L'Erario, C. Amlang (New York, USA)
Creating myPPMI: an Online Portal to Deliver Study Participant Content

C. Stanley, J. Talarico, C. Fitzgerald, C. Destro, M. Mcguire Kuhl, J. Schulze, L. Heathers, E. Flagg, B. Mcmahon, T. Foroud, T. Tropea, K. Fabrizio, K. Marek (New Haven, USA)
Creation and Performance of a Cognitive Summary Score in de novo Parkinson’s Disease: Results from the PPMI Study

M. Brumm, R. Kurth, M. York, D. Weintraub ()
Criteria Defining Chronic Pain Associated with Parkinson Disease

S. Perez-Lloret, J. Hunger, J. Bally, G. Kägi, J. Möller, N. Hollenstein, R. Gonzenbach, F. Brugger, D. Ciampi-de-Andrade, V. Mylius (Buenos Aires, Argentina)
Critically Evaluating Best Practice Guidelines for Cognitive Impairment in Parkinson’s Disease: A Systematic Review (PDCogniCare)

D. Pourzinal, D. Bailey, J. Yang, L. Mitchell, N. Pachana, D. Brooks, SA. Keramat, K. Shrubsole, J. Liddle, H. Tinson, S. Naismith, A. Lehn, R. Marsh, N. Dissanayaka (HERSTON, Australia)
Cross-cultural adaptation to Argentine Spanish and validation of the High Level Mobility Assessment Tool in individuals with Parkinson’s disease

G. Peker, J. Lopez Arrubla, J. Ortiz, N. Alva, M. Andreu, G. Williams, E. Gatto (Buenos Aires, Argentina)
Cross-Omics Clustering Identifies Common Molecular Patterns in Parkinson’s Disease

M. Lai, B. Benitez (Boston, USA)
Cross-sectional study: what is the sleep quality, daytime sleepiness and quality of life like of people with parkinson’s disease at different stages of the disease?

G. Leveck, L. Paladini, T. Christinelli, V. Israel (CURITIBA, Brazil)
Cryptococcal meningitis as a rare cause of acute generalized chorea: a report of an interesting case

C. Wantaneeyawong, C. Teekaput, K. Thiankhaw (Chiang Mai, Thailand)
CSF Neurogranin Levels Are Decreased in Parkinson Disease

H. Hwang, R. Miller, T. Cash, A. Eid, E. Herries, R. White Iii, B. Maiti, S. Schindler, J. Jackson, J. Perlmutter, M. Campbell, P. Kotzbauer (SAINT LOUIS, USA)
Cytokine Profiles as Biomarkers for Neurodegenerative Diseases: An inflammatory study on Parkinson’s Disease and Tauopathies

A. Jäck, W. Wilfert, C. Palleis, A. Bernhardt, E. Weidinger, S. Katzdobler, U. Fietzek, D. Teupser, J. Levin (Munich, Germany)